Arnoriaga Rodríguez, María (Date of defense: 2022-04-27)
Obesity is considered a modifiable risk factor for cognitive impairment which, in turn, predisposes to overeating and weight gain. Compelling evidence in animal models has demonstrated the impact of the ...
Ramió i Torrentà, Lluís (Date of defense: 2014-10-23)
Multiple sclerosis is a chronic neurological disease of the central nervous system with unknown, autoimmune mechanism, and a progressive and disabling course. Lipid-specific oligoclonal IgM bands in ...
Muñoz San Martín, María (Date of defense: 2021-09-15)
Multiple sclerosis (MS) is considered a chronic inflammatory and neurodegenerative disease, characterized by the existence of demyelinated areas in the central nervous system, infiltration of inflammatory ...
Gich Fullà, Jordi (Date of defense: 2013-07-18)
The clinical manifestations of Multiple Sclerosis are motor, sensitive, cerebellar and cognitive alterations. It evolves with a high degree of physical and cognitive disability. The “EM-line! Project” ...
Robles Cedeño, René (Date of defense: 2016-07-19)
Multiple sclerosis is a chronic disease of the central nervous system which has an unknown aetiology and an autoimmune mechanism. Two pathogenic processes, inflammation and neurodegeneration, converge ...
Gubern Mérida, M. Carme (Date of defense: 2015-12-18)
Cerebral ischaemia is a potent inducer of gene expression, however, little is known about the mechanisms that regulate this expression. Studies of gene expression and the study of the mechanisms regulating ...
Cabezas Llobet, Núria (Date of defense: 2019-02-28)
Huntington's disease (MH) is a progressive neurodegenerative disorder characterized by a motor dysfunction, cognitive impairment, and psychiatric symptoms. At neuropathological level, it has been described ...
Vidal Sancho, Laura (Date of defense: 2018-01-10)
Huntington disease is a neurodegenerative disorder characterized by motor, cognitive and psychiatric dysfunction. Huntington disease is caused by an expanded CAG trinucleotide repeat at the exon 1 of ...
Solés Tarrés, Irene (Date of defense: 2023-06-14)
Huntington’s disease (HD) is a neurodegenerative genetic disorder with no effective treatment characterized by motor discoordination, deficits in cognitive function (acquiring new knowledges, memory, ...
Blanco Silvente, Lídia (Date of defense: 2019-07-08)
The evidence available in the medical literature is conclusive that the risk-benefit relationship of the current medications for Alzheimer's disease is not favourable. This risk-benefit relationship is ...